Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria.
Prokaryotics is an authentic antibacterial discovery organization committed to bringing forth innovative therapeutics to address the problem of multidrug resistant bacteria and combating the emerging global crisis of antibiotic resistance.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 1000 Morris Avenue,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- prokaryotics.com
- Keywords
- will be essential to Prokaryotics as we move into our next phase of expansion and success..
- HQ
- Union, New Jersey
Prokaryotics, Inc. Questions
Prokaryotics, Inc.'s website is prokaryotics.com
Prokaryotics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/prokaryotics-inc
Prokaryotics, Inc. has
8 employees.
View email and phone details for 8
employees at Prokaryotics, Inc..
Prokaryotics, Inc.'s industry is
Pharmaceutical Manufacturing
Prokaryotics, Inc.'s top competitors are
Biospace,
Vertex Pharmaceuticals,
Biophase,
Avidity Biosciences, Inc.,
Biogen,
Carb-X,
Meet Life Sciences,
Immunocore,
Recruitseq,
Amgen.
Prokaryotics, Inc.'s categories are Pharmaceutical Manufacturing
Prokaryotics, Inc.'s founding year is 2017
